Dining upgrades a la 'cart'
Profile: On the side of seniors
Dementia-friendly ways to worship
By Jackie Vance
by Shelly Mesure
By Gary Tetz
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.